BIT
INFI

BlackRock Institutional Trust’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

BlackRock Institutional Trust’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.87M Sell
1,386,687
-68,630
-5% -$89.6K ﹤0.01% 3076
2016
Q3 		$2.27M Buy
1,455,317
+96,995
+7% +$149K ﹤0.01% 3001
2016
Q2 		$1.81M Buy
1,358,322
+131,117
+11% +$613K ﹤0.01% 3073
2016
Q1 		$6.47M Sell
1,227,205
-148,522
-11% -$909K ﹤0.01% 2529
2015
Q4 		$10.8M Sell
1,375,727
-1,629
-0.1% -$14K ﹤0.01% 2269
2015
Q3 		$11.6M Sell
1,377,356
-43,804
-3% -$404K ﹤0.01% 2188
2015
Q2 		$15.6M Sell
1,421,160
-14,484
-1% -$186K ﹤0.01% 2092
2015
Q1 		$20.1M Buy
1,435,644
+25,093
+2% +$384K ﹤0.01% 1930
2014
Q4 		$23.8M Buy
1,410,551
+92,702
+7% +$1.35M ﹤0.01% 1790
2014
Q3 		$17.7M Sell
1,317,849
-56,902
-4% -$678K ﹤0.01% 1950
2014
Q2 		$17.5M Buy
1,374,751
+13,355
+1% +$139K ﹤0.01% 2055
2014
Q1 		$16.2M Buy
1,361,396
+60,770
+5% +$815K ﹤0.01% 2101
2013
Q4 		$18M Buy
1,300,626
+24,133
+2% +$341K ﹤0.01% 2025
2013
Q3 		$22.2M Sell
1,276,493
-56,666
-4% -$1.09M ﹤0.01% 1779
2013
Q2 		$21.6M Buy
+1,333,159
New +$41.3M ﹤0.01% 1754

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Institutional Trust's INFI Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Infinity Pharmaceuticals, Inc. (INFI) stake by 4.7% in Q4 2016, selling an estimated $89.6K and leaving 1,386,687 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #3076.

BlackRock Institutional Trust first reported a position in INFI in Q2 2013 and has held it in 15 quarters since. The position peaked at $23.8M in Q4 2014. 94 funds tracked by Wall St. Rank hold INFI as of Q4 2016.

  • BlackRock Institutional Trust held 1,386,687 shares of Infinity Pharmaceuticals, Inc. worth $1.87M as of Q4 2016.
  • BlackRock Institutional Trust sold 68,630 Infinity Pharmaceuticals, Inc. shares in Q4 2016, an estimated $89.6K.
  • Infinity Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3076 holding.
  • BlackRock Institutional Trust first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Infinity Pharmaceuticals, Inc. position peaked at $23.8M in Q4 2014.
  • 94 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.